Academic Journal
Quartile not availableAmyotrophic Lateral Sclerosis
About Amyotrophic Lateral Sclerosis
About Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis is a peer-reviewed scholarly journal published by Taylor & Francis (GB). It focuses on Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, Hereditary Neurological Disorders, Alzheimer's disease research and treatments, Muscle Physiology and Disorders, Dementia and Cognitive Impairment Research, Multiple Sclerosis Research Studies, Amyloidosis: Diagnosis, Treatment, Outcomes, Genetic Neurodegenerative Diseases, Peripheral Neuropathies and Disorders.
Key indicators: ISSN 1471180X, 17482968; H-index 85.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (85): Strong citation impact — 85 articles cited at least 85 times each, reflecting solid influence.
Publishing in Amyotrophic Lateral Sclerosis
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, Hereditary Neurological Disorders, Alzheimer's disease research and treatments, Muscle Physiology and Disorders, Dementia and Cognitive Impairment Research, Multiple Sclerosis Research Studies, Amyloidosis: Diagnosis, Treatment, Outcomes, Genetic Neurodegenerative Diseases, Peripheral Neuropathies and Disorders. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Amyotrophic Lateral Sclerosis?
1471180X, 17482968.
Who publishes Amyotrophic Lateral Sclerosis?
Taylor & Francis.
What are Amyotrophic Lateral Sclerosis's metrics?
H-index 85.
Where do I submit to Amyotrophic Lateral Sclerosis?
Via the official website.
Is Amyotrophic Lateral Sclerosis peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Journal Metrics
A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
THEME 7 MULTIDISCIPLINARY CARE AND QUALITY OF LIFE
2012-10 · DOI: 10.3109/17482968.2012.721231iTHEME 5 GENETICS
2012-10 · DOI: 10.3109/17482968.2012.721231gTHEME 8 RESPIRATORY AND NUTRITIONAL MANAGEMENT
2012-10 · DOI: 10.3109/17482968.2012.721231jTHEME 2 IN VIVO EXPERIMENTAL MODELS
2012-10 · DOI: 10.3109/17482968.2012.721231dTHEME 6 EPIDEMIOLOGY
2012-10 · DOI: 10.3109/17482968.2012.721231hTHEME 9 COGNITIVE AND PSYCHOLOGICAL ASSESSMENT AND SUPPORT
2012-10 · DOI: 10.3109/17482968.2012.721231kAUTHOR INDEX
2012-10 · DOI: 10.3109/17482968.2012.721231oTHEME 3 IN VITRO EXPERIMENTAL MODELS
2012-10 · DOI: 10.3109/17482968.2012.721231eTHEME 1 THERAPEUTIC STRATEGIES
2012-10 · DOI: 10.3109/17482968.2012.721231cSUBJECT INDEX
2012-10 · DOI: 10.3109/17482968.2012.721231pTHEME 10 IMAGING, ELECTROPHYSIOLOGY AND MARKERS OF DISEASE PROGRESSION
2012-10 · DOI: 10.3109/17482968.2012.721231lINTRODUCTION
2012-10 · DOI: 10.3109/17482968.2012.721231aTHEME 4 HUMAN CELL BIOLOGY AND PATHOLOGY
2012-10 · DOI: 10.3109/17482968.2012.721231fTHEME 11 IMPROVING DIAGNOSIS, PROGNOSIS AND DISEASE PROGRESSION
2012-10 · DOI: 10.3109/17482968.2012.721231mPLATFORM COMMUNICATIONS
2012-10 · DOI: 10.3109/17482968.2012.721231bMarked intrafamilial phenotypic variation in a family with SOD1 C111Y mutation
Akinori Nakamura, Akiyo Hineno, Kunihiro Yoshida, Yoshiki Sekijima et al.
2012-09 · DOI: 10.3109/17482968.2012.656311Energy requirement assessed by doubly-labeled water method in patients with advanced amyotrophic lateral sclerosis managed by tracheotomy positive pressure ventilation
Noriko Ichihara, Kazuyoshi Namba, Kazuko Ishikawa-Takata, Kazunori Sekine et al.
2012-10 · DOI: 10.3109/17482968.2012.699968The impact of active coping strategies on survival in ALS: The first pilot study
Sébastien Montel, Laurence Albertini, Claude Desnuelle, Elisabeth Spitz et al.
2012-10 · DOI: 10.3109/17482968.2012.711835Unusual occurrence of amyotrophic lateral sclerosis in myasthenia gravis
Karkal Ravishankar Naik, Aralikatte Onkarappa Saroja, Manik Mahajan
2012-09 · DOI: 10.3109/17482968.2012.711836TDP-43 plasma levels are higher in amyotrophic lateral sclerosis
Esther Verstraete, H. Bea Kuiperij, Marka M. van Blitterswijk, Jan H. Veldink et al.
2012-09 · DOI: 10.3109/17482968.2012.703208Reviews
Community Reviews
Version History
October 11, 2026 at 2:12 pm
October 10, 2026